Effect of the 5-Hydroxytryptamine_3 (5-HT_3)-Receptor Antagonist KB-R6933 on Experimental Diarrhea Models

Access this Article

Author(s)

Abstract

The effects of a 5-hydroxytryptamine<SUB>3</SUB> (5-HT<SUB>3</SUB>)-receptor antagonist KB-R6933 (6-amino-5-chloro-1-isopropyl-2-(4-methyl-1-piperazinyl)-benzimidazole dimaleate) on experimental diarrhea and on intestinal fluid secretion stimulated by cholera toxin were examined and compared with those of ramosetron and loperamide. KB-R6933 and ramosetron (0.03 - 1 mg/kg, p.o.) inhibited the diarrhea induced by 5-HT, but not that by castor oil or prostaglandin E<SUB>2</SUB> (PGE<SUB>2</SUB>), in mice. Loperamide significantly inhibited the diarrhea induced by 5-HT, castor oil and PGE<SUB>2</SUB>. All drugs tested inhibited the diarrhea induced by restraint stress and the intestinal fluid secretion stimulated by cholera toxin in rats. The results suggest the possibility that KB-R6933 may have clinical efficacy in the treatment of diarrhea.

Journal

  • The Japanese Journal of Pharmacology

    The Japanese Journal of Pharmacology 80(1), 93-96, 1999-05-01

    The Japanese Pharmacological Society

References:  14

Cited by:  1

Codes

  • NII Article ID (NAID)
    10008194728
  • NII NACSIS-CAT ID (NCID)
    AA00691188
  • Text Lang
    ENG
  • Article Type
    Journal Article
  • ISSN
    00215198
  • NDL Article ID
    4733209
  • NDL Source Classification
    ZS51(科学技術--薬学)
  • NDL Call No.
    Z53-D199
  • Data Source
    CJP  CJPref  NDL  J-STAGE 
Page Top